Friday, 19 Jul 2019

You are here

40% of Arthritis Patients Fail to Receive Exercise Guidance

The latest issue of CDC’s MMWR reports that exercise counseling among arthritis patients increased from 52% to 61% (2002 to 2014); hence ~40% do not receive health care provider counseling, suggesting the need for provider education and training in exercise counseling, and improved electronic medical record reminders.

An estimated 54 million adults in the United States are affected by arthritis. Both American College of Rheumatology’s osteoarthritis management guidelines and Healthy People 2020 recommend regular physical activity or exercise among adults with arthritis.

The CDC analyzed 2002 and 2014 National Health Interview Survey (NHIS) data that included 36,697 adults; response rate = 58.9%). They were asked, “Have you ever been told by a doctor or other health care professional that you have arthritis, rheumatoid arthritis, gout, lupus or fibromyalgia?” and “Has a doctor or other health professional ever suggested physical activity or exercise to help your arthritis or joint symptoms?”

They found that between 2002 and 2014 there was a 17.6% increase (51.9% to 61.0% in the counseling of adult arthritis patients. This increase was greater (20.1%) in those who described themselves as inactive. 

By 2014, all subgroups exceeded the Healthy People 2020 age-standardized target of 57.4% for adults with arthritis, with the exception of non-Hispanic other races (53.8%), underweight/normal weight persons (50.0%), current smokers (56.9%), inactive persons (56.7%), and persons without a primary care provider (50.7%).

The CDC points out that Exercise is Medicine (EIM) website has free tools and resources to help providers incorporate these principles to improve chronic disease management in their practices.

Providers can reduce arthritis-specific barriers to exercise by referring patients who are uncertain about exercising safely to evidence-based, community programs. Several community group and self-directed exercise programs are available for adults with arthritis (e.g., Enhance Fitness, Walk with Ease, and Active Living Every Day) and can reduce pain and improve function, mobility, and mood. Community based organizations, including the National Parks and Recreation Association and the YMCA disseminate these evidence-based physical activity programs throughout the United States.

Particular attention should be paid to subgroups that have not reached the Healthy People 2020 target, including underweight/normal weight persons, current smokers, and certain racial/ethnic groups

Prevalence of health care provider counseling for exercise among adults with arthritis has increased significantly over more than a decade, but the prevalence of counseling remains low for a self-managed behavior (exercise) with proven benefits and few risks (8), especially among those who are inactive. Various strategies such as health care provider education and training in exercise counseling and electronic medical record prompts might increase health care provider counseling for exercise among adults with arthritis.

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

RheumNow Podcast – Don’t Take My Advice (7.19.19)

Dr. Jack Cush reports the news and new journal articles from the past week on RheumNow.com.

RheumNow Podcast – Boiling Hot MAS (7.12.19)

Dr. Jack Cush reviews this week's news and journal reports featured on RheumNow.com. PsA v. non-PsA pregnancies, Still's disease, lupus, nutritional supplements and dietary interventions, use of cannabis, tanezumab in OA, CBD oils and more.

Be ‘on point’: Guidelines for rheumatic complications of immunotherapy

Editor's note: July 1 - 5, RheumNow is running the best of the EULAR 2019 meeting. At EULAR 2019, Madrid, several recommendations including RA, SLE, and Sjogren’s syndrome have been developed. Agreement for principles with respect to the treatment of immune mediated adverse events from cancer immunotherapy are lacking.

RheumNow Podcast – EULAR 2019 Streamin' - (6.14.19)

Editor's note: July 1 - 5, RheumNow is running the best of the EULAR 2019 meeting. Dr. Jack Cush reports from Madrid on several novel presentations from EULAR 2019, including low-dose steroids in hand OA, ABA vs. ADA in double positive RA patients, psoriasis predictors of PsA, tildrakizumab and more.

EULAR 2019 – Day 3 Report

Editor's note: July 1 - 5, RheumNow is running the best of the EULAR 2019 meeting. The third day of EULAR 2019 started with novel biologics, the efficacy of secukinumab in axial psoriatic arthritis, neurologic events with TNF inhibitors from the DANBIO database (OP0261), and neuropathy in SLE (OP0252), but above all this was a big poster day. Here are selected highlights from day 3 EULAR in Madrid.